$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Clinical review: Probiotics in critical care 원문보기

Critical care CC, v.16 no.6, 2012년, pp.237 - 237  

Crooks, Neil H (Academic Department of Anaesthesia, Critical Care and Pain, Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK) ,  Snaith, Catherine (Academic Department of Anaesthesia, Critical Care and Pain, Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK) ,  Webster, Deborah (ACCS Anaesthetics, Derriford Hospital, Plymouth NHS Trust, Derriford Road, Plymouth, PL6 8DH, UK) ,  Gao, Fang (Perioperative, Critical Care and Trauma Trials Group, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK) ,  Hawkey, Peter (West Midlands Public Health Laboratory, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, UK)

Abstract AI-Helper 아이콘AI-Helper

Patients in ICUs represent a relatively small subgroup of hospitalised patients, but they account for approximately 25% of all hospital infections. Approximately 30% of ICU patients suffer from infection as a complication of critical illness, which increases the length of ICU stay, morbidity, mortal...

참고문헌 (97)

  1. Alverdy JC Laughlin RS Wu L Influence of the critically ill state on host- pathogen interactions within the intestine: gut-derived sepsis redefined Crit Care Med 2003 16 598 607 10.1097/01.CCM.0000045576.55937.67 12576972 

  2. Bengmark S Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients Clin Nutr 2004 16 441 445 10.1016/j.clnu.2004.01.005 15297078 

  3. MacFie J O'Boyle C Mitchell CJ Buckley PM Johnstone D Sudworth P Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity Gut 1999 16 223 228 10.1136/gut.45.2.223 10403734 

  4. Hassoun HT Kone BC Mercer DW Moody FG Weisbrodt NW Moore FA Post-injury multiple organ failure: the role of the gut Shock 2001 16 1 10 11198350 

  5. Sherman PM Ossa JC Johnson-Henry K Unraveling mechanisms of action of probiotics Nutr Clin Pract 2009 16 10 14 10.1177/0884533608329231 19244144 

  6. Guarner F Khan AG Garisch J Eliakim R Gangl A Thomson A World gastroenterology organisation global guidelines: probiotics and prebiotics october 2011 J Clin Gastroenterol 2012 16 468 481 10.1097/MCG.0b013e3182549092 22688142 

  7. Gibson GR Roberfroid MB Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics J Nutr 1995 16 1401 1412 7782892 

  8. Arumugam M Raes J Pelletier E Le Paslier D Yamada T Mende DR Fernandes GR Tap J Bruls T Batto J-M Bertalan M Borruel N Casellas F Fernandez L Gautier L Hansen T Hattori M Hayashi T Kleerebezem M Kurokawa K Leclerc M Levenez F Manichanh C Nielsen HB Nielsen T Pons N Poulain J Qin J Sicheritz-Ponten T Tims S Enterotypes of the human gut microbiome Nature 2011 16 174 180 10.1038/nature09944 21508958 

  9. Qin J Li R Raes J Arumugam M Burgdorf KS Manichanh C Nielsen T Pons N Levenez F Yamada T Mende DR Li J Xu J Li S Li D Cao J Wang B Liang H Zheng H Xie Y Tap J Lepage P Bertalan M Batto J-M Hansen T Le Paslier D Linneberg A Nielsen HB Pelletier E Renault P A human gut microbial gene catalogue established by metagenomic sequencing Nature 2010 16 59 65 10.1038/nature08821 20203603 

  10. Sepp E Mikelsaar M Salminen S Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns Microb Ecol Health Dis 1993 16 309 314 10.3109/08910609309141340 

  11. Benno Y He F Hosoda M Hashimoto H Kojima T Yamazaki K Iino H Mykkanen H Salminen S Effect of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects Nutr Today 1996 16 Suppl 1 9s 11s 

  12. Fayol-Messaoudi D Berger CN Coconnier-Polter M-H Liévin-Le Moal V Servin AL pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium Appl Environ Microbiol 2005 16 6008 6013 10.1128/AEM.71.10.6008-6013.2005 16204515 

  13. Venturi A Gionchetti P Rizzello F Johansson R Zucconi E Brigidi P Matteuzzi D Campieri M Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis Aliment Pharmacol Ther 1999 16 1103 1108 10.1046/j.1365-2036.1999.00560.x 10468688 

  14. Corr SC Li Y Riedel CU O'Toole PW Hill C Gahan CGM Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 Proc Natl Acad Sci USA 2007 16 7617 7621 10.1073/pnas.0700440104 17456596 

  15. Ng SC Hart AL Kamm MA Stagg AJ Knight SC Mechanisms of action of probiotics: recent advances Inflamm Bowel Dis 2009 16 300 310 10.1002/ibd.20602 18626975 

  16. Flynn S van Sinderen D Thornton GM Holo H Nes IF Collins JK Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118 Microbiology 2002 16 973 984 11932444 

  17. Medellin-Peña MJ Wang H Johnson R Anand S Griffiths MW Probiotics affect virulence-related gene expression in Escherichia coli O157:H7 Appl Environ Microbiol 2007 16 4259 4267 10.1128/AEM.00159-07 17496132 

  18. Mack DR Michail S Wei S McDougall L Hollingsworth MA Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression Am J Physiol 1999 16 G941 G950 10198338 

  19. Walker WA Mechanisms of action of probiotics Clin Infect Dis 2008 16 Suppl 2 S87 S91 discussion S144-S151 18181730 

  20. Allen SJ Okoko B Martinez E Gregorio G Dans LF Probiotics for treating infectious diarrhoea Cochrane Database Syst Rev 2004 16 CD003048 15106189 

  21. Gatt M Reddy BS MacFie J Review article: bacterial translocation in the critically ill - evidence and methods of prevention Aliment Pharmacol Ther 2007 16 741 757 17373913 

  22. Shimizu K Ogura H Hamasaki T Goto M Tasaki O Asahara T Nomoto K Morotomi M Matsushima A Kuwagata Y Sugimoto H Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome Dig Dis Sci 2011 16 1171 1177 10.1007/s10620-010-1418-8 20931284 

  23. Inglis TJJ Sherratt MJ Sproat LJ Hawkey PM Gibson JS Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung The Lancet 1993 16 911 913 10.1016/0140-6736(93)91208-4 

  24. McNaught CE Woodcock NP MacFie J Mitchell CJ A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients Gut 2002 16 827 831 10.1136/gut.51.6.827 12427785 

  25. Anderson ADG McNaught CE Jain PK MacFie J Randomised clinical trial of synbiotic therapy in elective surgical patients Gut 2004 16 241 245 10.1136/gut.2003.024620 14724157 

  26. Reddy BS Macfie J Gatt M Larsen CN Jensen SS Leser TD Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy Br J Surg 2007 16 546 554 10.1002/bjs.5705 17443852 

  27. Nomura T Tsuchiya Y Nashimoto A Yabusaki H Takii Y Nakagawa S Sato N Kanbayashi C Tanaka O Probiotics reduce infectious complications after pancreaticoduodenectomy Hepatogastroenterology 2007 16 661 663 17591036 

  28. Rayes N Seehofer D Theruvath T Mogl M Langrehr JM Nüssler NC Bengmark S Neuhaus P Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial Ann Surg 2007 16 36 41 10.1097/01.sla.0000259442.78947.19 17592288 

  29. Kanazawa H Nagino M Kamiya S Komatsu S Mayumi T Takagi K Asahara T Nomoto K Tanaka R Nimura Y Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy Langenbecks Arch Surg 2005 16 104 113 10.1007/s00423-004-0536-1 15711820 

  30. Sugawara G Nagino M Nishio H Ebata T Takagi K Asahara T Nomoto K Nimura Y Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial Ann Surg 2006 16 706 714 10.1097/01.sla.0000219039.20924.88 17060763 

  31. Rayes N Seehofer D Hansen S Boucsein K Müller AR Serke S Bengmark S Neuhaus P Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients Transplantation 2002 16 123 127 10.1097/00007890-200207150-00021 12134110 

  32. Rayes N Seehofer D Theruvath T Schiller RA Langrehr JM Jonas S Bengmark S Neuhaus P Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial Am J Transplant 2005 16 125 130 10.1111/j.1600-6143.2004.00649.x 15636620 

  33. Oláh A Belágyi T Issekutz A Gamal ME Bengmark S Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis Br J Surg 2002 16 1103 1107 10.1046/j.1365-2168.2002.02189.x 12190674 

  34. Oláh A Belágyi T Pótó L Romics L Jr Bengmark S Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study Hepatogastroenterology 2007 16 590 594 17523328 

  35. Besselink MGH van Santvoort HC Buskens E Boermeester MA van Goor H Timmerman HM Nieuwenhuijs VB Bollen TL van Ramshorst B Witteman BJM Rosman C Ploeg RJ Brink MA Schaapherder AFM Dejong CHC Wahab PJ van Laarhoven CJHM van der Harst E van Eijck CHJ Cuesta MA Akkermans LMA Gooszen HG Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 2008 16 651 659 10.1016/S0140-6736(08)60207-X 18279948 

  36. Vincent JL Bihari DJ Suter PM Bruining HA White J Nicolas-Chanoin MH Spencer RC Hemmer M The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee JAMA 1995 16 639 644 10.1001/jama.1995.03530080055041 7637145 

  37. Vincent J-L Rello J Marshall J Silva E Anzueto A Martin CD Moreno R Lipman J Gomersall C Sakr Y Reinhart K International study of the prevalence and outcomes of infection in intensive care units JAMA 2009 16 2323 2329 10.1001/jama.2009.1754 19952319 

  38. Morrow LE Kollef MH Casale TB Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial Am J Respir Crit Care Med 2010 16 1058 1064 10.1164/rccm.200912-1853OC 20522788 

  39. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 2005 16 388 416 15699079 

  40. Vincent J-L Sakr Y Sprung CL Ranieri VM Reinhart K Gerlach H Moreno R Carlet J Le Gall J-R Payen D Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006 16 344 353 10.1097/01.CCM.0000194725.48928.3A 16424713 

  41. Kollef MH Shorr A Tabak YP Gupta V Liu LZ Johannes RS Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia Chest 2005 16 3854 3862 10.1378/chest.128.6.3854 16354854 

  42. Liberati A D'Amico R Pifferi S Torri V Brazzi L Parmelli E Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care Cochrane Database Syst Rev 2009 16 CD000022 19821262 

  43. de Smet AMGA Kluytmans JAJW Cooper BS Mascini EM Benus RFJ van der Werf TS van der Hoeven JG Pickkers P Bogaers-Hofman D van der Meer NJM Bernards AT Kuijper EJ Joore JCA Leverstein-van Hall MA Bindels AJGH Jansz AR Wesselink RMJ de Jongh BM Dennesen PJW van Asselt GJ te Velde LF Frenay IHME Kaasjager K Bosch FH van Iterson M Thijsen SFT Kluge GH Pauw W de Vries JW Kaan JA Decontamination of the digestive tract and oropharynx in ICU patients N Engl J Med 2009 16 20 31 10.1056/NEJMoa0800394 19118302 

  44. Oostdijk EAN de Smet AMGA Blok HEM Thieme Groen ES van Asselt GJ Benus RFJ Bernards SAT Frénay IHME Jansz AR de Jongh BM Kaan JA Leverstein-van Hall MA Mascini EM Pauw W Sturm PDJ Thijsen SFT Kluytmans JAJW Bonten MJM Ecological effects of selective decontamination on resistant gram-negative bacterial colonization Am J Respir Crit Care Med 2010 16 452 457 10.1164/rccm.200908-1210OC 19965807 

  45. García-San Vicente B Canut A Labora A Otazua M Corral E [Selective decontamination of the digestive tract: repercussions on microbiology laboratory workload and costs, and antibiotic resistance trends] Enferm Infecc Microbiol Clin 2010 16 75 81 10.1016/j.eimc.2009.03.005 19632746 

  46. Al Naiemi N Heddema ER Bart A de Jonge E Vandenbroucke-Grauls CM Savelkoul PHM Duim B Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit J Antimicrob Chemother 2006 16 853 856 10.1093/jac/dkl316 16891326 

  47. Kotzampassi K Giamarellos-Bourboulis EJ Voudouris A Kazamias P Eleftheriadis E Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial World J Surg 2006 16 1848 1855 10.1007/s00268-005-0653-1 16983476 

  48. Spindler-Vesel A Bengmark S Vovk I Cerovic O Kompan L Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients JPEN J Parenter Enteral Nutr 2007 16 119 126 10.1177/0148607107031002119 17308252 

  49. Forestier C Guelon D Cluytens V Gillart T Sirot J De Champs C Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients Crit Care 2008 16 R69 10.1186/cc6907 18489775 

  50. Klarin B Molin G Jeppsson B Larsson A Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study Crit Care 2008 16 R136 10.1186/cc7109 18990201 

  51. Knight DJW Gardiner D Banks A Snape SE Weston VC Bengmark S Girling KJ Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebocontrolled trial Intensive Care Med 2009 16 854 861 10.1007/s00134-008-1368-1 19083199 

  52. Oudhuis GJ Bergmans DC Dormans T Zwaveling J-H Kessels A Prins MH Stobberingh EE Verbon A Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality Intensive Care Med 2011 16 110 117 10.1007/s00134-010-2002-6 20721536 

  53. Barraud D Blard C Hein F Marçon O Cravoisy A Nace L Alla F Bollaert P-E Gibot S Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial Intensive Care Med 2010 16 1540 1547 10.1007/s00134-010-1927-0 20502866 

  54. Watkinson PJ Barber VS Dark P Young JD The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review Clin Nutr 2007 16 182 192 10.1016/j.clnu.2006.07.010 17011083 

  55. Siempos II Ntaidou TK Falagas ME Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials Crit Care Med 2010 16 954 962 10.1097/CCM.0b013e3181c8fe4b 20016381 

  56. Knight D Ala'Aldeen D Bengmark S Girling K The effect of probiotics on gastrointestinal flora in the critically ill Br J Anaesth 2004 16 307 308 

  57. Tuomola E Crittenden R Playne M Isolauri E Salminen S Quality assurance criteria for probiotic bacteria Am J Clin Nutr 2001 16 393S 398S 11157347 

  58. Clements ML Levine MM Ristaino PA Daya VE Hughes TP Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease Prog Food Nutr Sci 1983 16 29 37 6657981 

  59. Isakow W Morrow LE Kollef MH Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations Chest 2007 16 286 294 10.1378/chest.06-2156 17625089 

  60. Salminen MK Rautelin H Tynkkynen S Poussa T Saxelin M Valtonen V Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG Clin Infect Dis 2004 16 62 69 10.1086/380455 14679449 

  61. Salminen MK Tynkkynen S Rautelin H Saxelin M Vaara M Ruutu P Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland Clin Infect Dis 2002 16 1155 1160 10.1086/342912 12410474 

  62. Rautio M Jousimies-Somer H Kauma H Pietarinen I Saxelin M Tynkkynen S Koskela M Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG Clin Infect Dis 1999 16 1159 1160 10.1086/514766 10452653 

  63. Mackay A Taylor M Kibbler C Hamilton-Miller J Lactobacillus endocarditis caused by a probiotic organism Clin Microbiol Infect 1999 16 290 292 10.1111/j.1469-0691.1999.tb00144.x 11856270 

  64. Kunz A Noel J Fairchok M Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome J Pediatr Gastroenterol Nutr 2004 16 457 458 10.1097/00005176-200404000-00017 15085028 

  65. Land M Rouster-Stecens K Woods C Cannon M Cnota J Shetty A Lactobacillus sepsis associated with probiotic therapy Pediatrics 2005 16 178 181 15629999 

  66. Abgrall S Joly V Derkinderen P Decré D Carbon C Yeni P Lactobacillus casei infection in an AIDS patient Eur J Clin Microbiol Infect Dis 1997 16 180 182 10.1007/BF01709485 9105853 

  67. Jones SD Fullerton DA Zamora MR Badesch DB Campbell DN Grover FL Transmission of Lactobacillus pneumonia by a transplanted lung Ann Thorac Surg 1994 16 887 889 10.1016/0003-4975(94)90779-X 7944727 

  68. Patel R Cockerill FR Porayko MK Osmon DR Ilstrup DM Keating MR Lactobacillemia in liver transplant patients Clin Infect Dis 1994 16 207 212 10.1093/clinids/18.2.207 8161628 

  69. Saxelin M Chuang NH Chassy B Rautelin H Mäkelä PH Salminen S Gorbach SL Lactobacilli and bacteremia in southern Finland, 1989-1992 Clin Infect Dis 1996 16 564 566 10.1093/clinids/22.3.564 8852980 

  70. Guenther K Straube E Pfister W Guenther A Huebler A Severe sepsis after probiotic treatment with Escherichia coli NISSLE 1917 Pediatr Infect Dis J 2010 16 188 189 20118747 

  71. Timmerman HM Niers LEM Ridwan BU Koning CJM Mulder L Akkermans LMA Rombouts FM Rijkers GT Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients Clin Nutr 2007 16 450 459 10.1016/j.clnu.2007.04.008 17544549 

  72. Hawkey PM Jones AM The changing epidemiology of resistance J Antimicrob Chemother 2009 16 Suppl 1 i3 i10 19675017 

  73. Kumarasamy KK Toleman MA Walsh TR Bagaria J Butt F Balakrishnan R Chaudhary U Doumith M Giske CG Irfan S Krishnan P Kumar AV Maharjan S Mushtaq S Noorie T Paterson DL Pearson A Perry C Pike R Rao B Ray U Sarma JB Sharma M Sheridan E Thirunarayan MA Turton J Upadhyay S Warner M Welfare W Livermore DM Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 2010 16 597 602 10.1016/S1473-3099(10)70143-2 20705517 

  74. Adlerberth I Ahrne S Johansson ML Molin G Hanson LA Wold AE A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29 Appl Environ Microbiol 1996 16 2244 2251 8779562 

  75. Forestier C De Champs C Vatoux C Joly B Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties Res Microbiol 2001 16 167 173 10.1016/S0923-2508(01)01188-3 11316370 

  76. Otte J-M Podolsky DK Functional modulation of enterocytes by Grampositive and Gram-negative microorganisms Am J Physiol Gastrointest Liver Physiol 2004 16 G613 G626 10.1152/ajpgi.00341.2003 15010363 

  77. Wehkamp J Harder J Wehkamp K Wehkamp-von Meissner B Schlee M Enders C Sonnenborn U Nuding S Bengmark S Fellermann K Schröder JM Stange EF NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium Infect Immun 2004 16 5750 5758 10.1128/IAI.72.10.5750-5758.2004 15385474 

  78. Resta-Lenert S Barrett KE Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) Gut 2003 16 988 997 10.1136/gut.52.7.988 12801956 

  79. Meddings J The significance of the gut barrier in disease Gut 2008 16 438 440 18334657 

  80. Sherman PM Johnson-Henry KC Yeung HP Ngo PSC Goulet J Tompkins TA Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements Infect Immun 2005 16 5183 5188 10.1128/IAI.73.8.5183-5188.2005 16041036 

  81. Yan F Polk DB Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells J Biol Chem 2002 16 50959 50965 10.1074/jbc.M207050200 12393915 

  82. Ichikawa H Kuroiwa T Inagaki A Shineha R Nishihira T Satomi S Sakata T Probiotic bacteria stimulate gut epithelial cell proliferation in rat Dig Dis Sci 1999 16 2119 2123 10.1023/A:1026647024077 10548366 

  83. de Champs C Maroncle N Balestrino D Rich C Forestier C Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption J Clin Microbiol 2003 16 1270 1273 10.1128/JCM.41.3.1270-1273.2003 12624065 

  84. Reissbrodt R Hammes WP dal Bello F Prager R Fruth A Hantke K Rakin A Starcic-Erjavec M Williams PH Inhibition of growth of Shiga toxinproducing Escherichia coli by nonpathogenic Escherichia coli FEMS Microbiol Lett 2009 16 62 69 10.1111/j.1574-6968.2008.01405.x 19016876 

  85. Shi HN Walker A Bacterial colonization and the development of intestinal defences Can J Gastroenterol 2004 16 493 500 15372112 

  86. Akira S Takeda K Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2001 16 675 680 10.1038/90609 11477402 

  87. Ulisse S Gionchetti P D'Alò S Russo FP Pesce I Ricci G Rizzello F Helwig U Cifone MG Campieri M De Simone C Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment Am J Gastroenterol 2001 16 2691 2699 10.1111/j.1572-0241.2001.04139.x 11569697 

  88. Pathmakanthan S Li CKF Cowie J Hawkey CJ Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon J Gastroenterol Hepatol 2004 16 166 173 10.1111/j.1440-1746.2004.03181.x 14731126 

  89. Borruel N Carol M Casellas F Antolín M de Lara F Espín E Naval J Guarner F Malagelada JR Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria Gut 2002 16 659 664 10.1136/gut.51.5.659 12377803 

  90. Arribas B Rodríguez-Cabezas ME Camuesco D Comalada M Bailón E Utrilla P Nieto A Concha A Zarzuelo A Gálvez J A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice Br J Pharmacol 2009 16 1024 1033 10.1111/j.1476-5381.2009.00270.x 19486007 

  91. Kaila M Isolauri E Soppi E Virtanen E Laine S Arvilommi H Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain Pediatr Res 1992 16 141 144 10.1203/00006450-199208000-00002 1324462 

  92. Isolauri E Juntunen M Rautanen T Sillanaukee P Koivula T A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children Pediatrics 1991 16 90 97 1905394 

  93. Teitelbaum JE Walker WA Nutritional impact of pre- and probiotics as protective gastrointestinal organisms Annu Rev Nutr 2002 16 107 138 10.1146/annurev.nutr.22.110901.145412 12055340 

  94. Shida K Nanno M Nagata S Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities Gut Microbes 2011 16 109 114 10.4161/gmic.2.2.15661 21637028 

  95. Takeda K Suzuki T Shimada S-I Shida K Nanno M Okumura K Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota Clin Exp Immunol 2006 16 109 115 10.1111/j.1365-2249.2006.03165.x 16968405 

  96. Hatcher GE Lambrecht RS Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria J Dairy Sci 1993 16 2485 2492 10.3168/jds.S0022-0302(93)77583-9 8227651 

  97. Kruis W Fric P Pokrotnieks J Lukás M Fixa B Kascák M Kamm MA Weismueller J Beglinger C Stolte M Schulze J Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 2004 16 1617 1623 10.1136/gut.2003.037747 15479682 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로